908 DEVICES INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.98 USD | +5.47% |
|
+3.58% | -48.40% |
| 03-12 | 908 Devices Inc. Trace Chemical Identification Technology Adopted by European Agencies | CI |
| 03-05 | Transcript : 908 Devices Inc., Q4 2023 Earnings Call, Mar 05, 2024 |
| Sales 2024 * | 52.9M 4.22B | Sales 2025 * | 62.38M 4.98B | Capitalization | 187M 14.89B |
|---|---|---|---|---|---|
| Net income 2024 * | -41M -3.27B | Net income 2025 * | -38M -3.03B | EV / Sales 2024 * | 3.53 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.99 x |
| P/E ratio 2024 * |
-4.53
x | P/E ratio 2025 * |
-5.02
x | Employees | 230 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.34% |
More Fundamentals
* Assessed data
More news
Latest transcript on 908 Devices Inc.
More recommendations
More press releases
| 1 day | +5.38% | ||
| 1 week | +3.58% | ||
| Current month | -23.31% | ||
| 1 month | -16.09% | ||
| 3 months | -25.10% | ||
| 6 months | +10.29% | ||
| Current year | -48.40% |
1 week
5.40
6.09
1 month
5.407.56
Current year
5.4011.16
1 year
4.8512.51
3 years
4.8553.66
5 years
4.8579.60
10 years
4.8579.60
| Managers | Title | Age | Since |
|---|---|---|---|
Scott Miller
FOU | Founder | - | 31/12/11 |
Michael Jobin
FOU | Founder | - | 31/12/11 |
| Founder | 49 | 31/12/11 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
E. Hrusovsky
CHM | Chairman | 63 | 31/08/13 |
Keith Crandell
BRD | Director/Board Member | 63 | 31/05/12 |
| 66 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.51% | 1 M€ | 0.00% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/04/24 | 5.79 | +2.12% | 18 822 |
| 26/04/24 | 5.67 | +1.98% | 124,453 |
| 25/04/24 | 5.56 | -1.07% | 147,367 |
| 24/04/24 | 5.62 | +1.08% | 159,155 |
| 23/04/24 | 5.56 | -0.54% | 265,467 |
Delayed Quote Nasdaq, April 29, 2024 at 03:03 pm
More quotes
908 Devices Inc. offers a suite of purpose-built handheld and desktop mass spectrometry (Mass Spec) devices for the point of need chemical and biochemical analysis. The Company's Mass Spec devices are used at the point of need to interrogate unknown and invisible materials and provide answers to address problems in life sciences research, bioprocessing, industrial biotechnology, forensics and adjacent markets. Its products include MX908, Rebel, ZipChip, Maven and Maverick. MX908 is a handheld, battery-powered, Mass Spec device designed for the analysis of solid, liquid, vapor and aerosol materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. The Rebel is a small desktop analyzer providing real-time information on the extracellular environment in bioprocesses.
Calendar
30/04/2024
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
5.67
USD
Average target price
15.33
USD
Spread / Average Target
+170.43%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -48.40% | 187M | |
| -11.79% | 19.08B | |
| -45.24% | 2.65B | |
| +18.15% | 1.87B | |
| -3.12% | 1.61B | |
| +25.65% | 1.21B | |
| -10.69% | 1.02B | |
| -20.89% | 905M | |
| -5.01% | 716M | |
| -17.37% | 682M |
- Stock Market
- Equities
- MASS Stock
